SCHEMBL6833175

SCHEMBL6833175

CC(C)Sc1ncccc1C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
DDB1 Q16531 1/20 0.45
CRBN Q96SW2 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 1/20 0.44
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
AHR P35869 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
GAA P10253 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5962395 0.85 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10MAPTSMN1; SMN2
SCHEMBL1327237 0.81 KMT2A (0.56) PARP1ALDH1A1KDM4EHPGDRAB9A
SCHEMBL1328541 0.77 ALDH1A1 (0.51) PARP1DDB1CRBNALDH1A1KDM4E
SCHEMBL3429807 0.75 PARP1 (0.53) PARP1ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL740927 0.74 HSD11B1 (0.57) PARP1ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL10647365 0.73 KDM4E (0.48) PARP1ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL5087696 0.73 SMN1; SMN2 (0.61) PARP1DDB1CRBNALDH1A1SMN1; SMN2
SCHEMBL11096767 0.73 DDB1 (0.48) PARP1DDB1CRBNALDH1A1KDM4E
SCHEMBL8538146 0.73 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10HPGDRAB9A
SCHEMBL6752009 0.73 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed